cbdMD, Inc. has regained full compliance with the continued listing standards of the NYSE American, removing the ".BC" indicator from the list of noncompliant issuers.
The Company resolved all deficiencies related to Sections 1003(a)(i) and (ii) of the NYSE American Company Guide, as confirmed in a letter from NYSE American.
cbdMD's successful Series A Preferred share conversion in May and capital raise completed in September were key components of its compliance strategy.
Regained Compliance
cbdMD has successfully resolved all deficiencies and regained compliance with NYSE American listing standards.
Key Achievements
The successful Series A Preferred share conversion and capital raise were essential for strengthening cbdMD's balance sheet.
Long-Term Vision
The Company remains committed to maintaining strong financial discipline and governance for sustainable growth.
- cbdMD's compliance with NYSE American listing standards is a significant achievement that reflects the Company's efforts to strengthen its position for sustainable growth.
- Maintaining compliance demonstrates the commitment of investors and stakeholders to cbdMD's long-term vision.
cbdMD, Inc. has demonstrated resilience and strategic planning in regaining compliance with NYSE American listing standards, setting a positive trajectory for future growth and shareholder value.